Skip to content

Attention Control Training (ACT) in PTSD patients: a randomized controlled trial.

Attention Control Training (ACT) in PTSD patients: a randomized controlled trial. - ACT-IPP

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON55472
Enrollment
66
Registered
2021-05-18
Start date
2021-05-20
Completion date
Unknown
Last updated
2024-04-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

trauma-en stressorgerelateerde stoornis (PTSS) trauma-related disorder(s)

Interventions

ACT training involves a simple computerized performance task, that is non-invasive, requires little cognitive effort, and does not affect the personal integrity of participants. Performing reaction

Sponsors

Universiteit Utrecht
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Participants are admitted if PTSD has been determined in the intake with the help of the PCL-5 and LEC-5 and CAPS.

Exclusion criteria

Exclusion criteria: The exclusion criteria are: 1) psychotic or bipolar disorder 2) nonfluent Dutch 3) patient does not have a computer 4) no internet access at home 5) inability to use a computer keyboard 6) current psychotherapy 7) use of psychotropic medication that started within the past year. Participants will be removed from the study if their medication has to be changed during the trial. They will be admitted if they have been taking a stable dose of medication for at least 1 year.

Design outcomes

Primary

MeasureTime frame
The most important primary research variable is the (differential) decrease in PTSD symptomatology between the experimental group and the control group from baseline (T0) to post-EMDR (T2). We use the PCL-5 to measure this. The 20 items of the PCL-5 can be answered on a 5-point scale from *Not at all* (0) to *Extremely much* (4). Completing the PCL-5 takes about 5-10 minutes. The interpretation of the PCL-5 should be made by a clinician. PCL-5 scores demonstrated similarly strong reliability and validity. Overall, results indicate that the PCL-5 is a psychometrically sound measure of PTSD symptoms (Blevins & Weathers & Davis & Witte & Domino, 2015).

Secondary

MeasureTime frame
The secondary research variables are the differences in general well-being; degree of aggression and quality of life between the experimental group and the control group. We use the PHQ-9, AGQ and ORS questionnaires to measure this. The PHQ-9 questionnaire consists of 9 questions about the severity of depressive complaints based on the DSM IV criteria, with a maximum score of 27 points. The AGQ is a 29-item, four-factor instrument that measures physical aggression, verbal aggression, anger, and hostility. The ORS is a simple, four-item session-by-session measure designed to assess areas of life functioning known to change as a result of therapeutic intervention. These include: symptom distress, interpersonal well-being, social role, and overall well-being. The ORS translates these four dimensions of functioning into four visual analogue scales which are 10cm lines, with instructions to place a mark on each line with low estimate to the left and high to the right.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)